… stroke prevention in patients with atrial fibrillation (AF)… utility values of warfarin and aspirin
were retrieved from a quality-of-life analysis of these two agents [Citation28], whereas the utility …

… With no quality-of-life/utility adjustments, the incremental cost-effectiveness ratio was $183
… ablation in patients with atrial fibrillation and the subgroup of patients with concomitant heart …

… fibrillation had recurred, we assumed that patients would spend half of the 3-month model
cycle in atrial fibrillation … Likewise, the range of estimates for the annual cost and patient utility …

… Utility decrements associated with permanent events were applied for the remainder of
patients' … treated with apixaban had a similar safety profile to aspirin, 9 the same utility losses …

… Patients with persistent or longstanding atrial fibrillation have … morbidity and health care costs.
The convergent procedure has … of utility values on outcomes, several utility scenarios were …

… utility value calculation are not a complete match for our study cohort and intervention. However,
we think the utility … state in this study, the gain in utility value may even be a conservative …

… available regarding utilities in patients with AF, 33 particularly in AF ablation populations.
To address this lack of data, we derived utilities for 3 separate populations of patients with AF …

… year; utilities were estimated using the German EQ-5D-3L valuation algorithm. Because
utility information was only available at planned study visits, we assumed that the utility in dates …

… Costs and utility data were drawn from public data and the literature, while event
probabilities were derived from both the literature and rivaroxaban’s pivotal ROCKET AF trial. …

… in patients with nonvalvular atrial fibrillation. Secondary objectives related to assessing the
cost-… Utility values and costs were obtained from published data. Numerous deterministic …